Background illustration for clinical trials search

Paid Clinical Trials Tampa

Discover 1,443 paid clinical trials in Tampa, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,443

Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

for

Tardive Dyskinesia

Location: Tampa FL, Orange City FL, Bonita Springs FL,

Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 70+

Code: NCT07365462

Phase2, Recruiting

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

for

Lupus Erythematosus, Systemic

Location: Tampa FL, Clearwater FL, Plantation FL, Miami Lakes FL,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 70+

Code: NCT07438496

Phase3, Recruiting

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

for

Severe Asthma

Location: Tampa FL, Orlando FL, Tamarac FL, Miami FL,

Sponsor: Generate Biomedicines

Sex: All

Age: 12 - 70+

Code: NCT07359846

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

for

Arthritis, Psoriatic

Location: Tampa FL, Clearwater FL, Winter Park FL, Plantation FL,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07321873

Phase2, Recruiting

A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)

for

Haematologic Neoplasms

Location: Tampa FL, Houston TX

Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07064122

Phase1, Recruiting

A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

for

Sjögren's Disease

Location: Tampa FL, Bellaire TX, Duncansville PA,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07737743

Phase2, Recruiting

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

for

Systemic Lupus Erythematosus

Location: Tampa FL, Aventura FL, Memphis TN, Fayetteville NC,

Sponsor: Boehringer Ingelheim

Sex: All

Age: 18 - 70+

Code: NCT07409181

Phase2, Recruiting

A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

for

Prostate Cancer

Location: Tampa FL, Orlando FL, Commack NY, Grand Rapids MI,

Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT07192614

Phase1, Phase2, Recruiting

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

for

Major Depressive Disorder

Location: Tampa FL, Orlando FL, Miami Gardens FL, Charlotte NC,

Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT07196501

Phase3, Recruiting

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

for

Schizophrenia, Schizoaffective Disorder, Bipolar Disorder,

Location: Tampa FL, Port Charlotte FL, Orange City FL,

Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT07105111

Recruiting

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for

Prostate Cancer

Location: Tampa FL, Jacksonville FL, Hialeah FL, Newnan GA,

Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT06952803

Phase3, Recruiting

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

for

Relapsed AL Amyloidosis, Refractory AL Amyloidosis,

Location: Tampa FL, Nashville TN, St Louis MO, Cleveland OH,

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07081646

Phase1, Phase2, Recruiting

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

for

Diffuse Cutaneous Systemic Sclerosis

Location: Tampa FL, Clearwater FL, Sarasota FL, Baltimore MD,

Sponsor: Mediar Therapeutics

Sex: All

Age: 18+

Code: NCT07287670

Phase2, Recruiting

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

for

Schizophrenia

Location: Tampa FL, Maitland FL, West Palm Beach FL, Miami FL,

Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07227818

Phase3, Recruiting

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

for

Psychosis Associated With Alzheimer's Disease

Location: Tampa FL, Orlando FL, Naples FL, West Palm Beach FL,

Sponsor: MapLight Therapeutics

Sex: All

Age: 55 - 70+

Code: NCT06887192

Phase2, Recruiting

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

for

Schizophrenia

Location: Tampa FL, Maitland FL, West Palm Beach FL, Atlantis FL,

Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07114874

Phase3, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for

Cardiovascular Disease

Location: Tampa FL, Safety Harbor FL, Palm Harbor FL,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

for

Chronic Obstructive Pulmonary Disease (COPD)

Location: Tampa FL, Brandon FL, Clearwater FL, Sarasota FL,

Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT07082738

Phase2, Recruiting

Observational Study Protocol: LIVER-R

for

Hepatobiliary Cancers

Location: Tampa FL, Clermont FL, Gainesville FL, Augusta GA,

Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06252753

Recruiting

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for

Delayed Graft Function, DGF, Kidney Transplant

Location: Tampa FL, Jacksonville FL, Atlanta GA, Greenville SC,

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06830798

Phase3, Recruiting

Paid Clinical Trials Tampa

Filter results

Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)

Interested in new trials?

A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Observational Study Protocol: LIVER-R

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation